- Motley Fool•19 hours ago
Biogen's list price for a new rare-disease drug makes it one of the world's most expensive. Was that a mistake?
Ionis Pharmaceuticals, Inc. (IONS) is scheduled to report fourth-quarter 2016 results on Feb 28.
- Motley Fool•7 days ago
Here's what makes the pipelines of Celgene, Ionis, and Ligand among the best of all biotechs.
ISIS : Summary for Ionis Pharmaceuticals, Inc - Yahoo Finance
NasdaqGS . Currency in USD
Add to watchlist
|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's Range||N/A - N/A|
|52 Week Range||undefined - undefined|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||N/A|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|